Post Blogs, Photos, Youtube, Vimeo Videos, Topics, Events, Groups.
+ Larger Font | - Smaller Font

Welcome to Robins Social Network

Be part of the community and join us today!

Furosemide Market Projected to Witness Vigorous Expansion by 2027

Furosemide is a medication used to reduce edema (extra fluid in the body) due to diseases/conditions such as kidney disease, heart disease, and liver disease. It is also used for the treatment of high blood pressure. Furosemide is sulfamoylanthranilic acid derivative. It is also known as diuretic and is primarily administered orally or intravenously.

The injectable or intravenous form is used when the drug cannot be administered orally, especially in patients with chronic diseases. The medication helps the kidneys eliminate unneeded water and salt from the body through urine. It blocks the absorption of sodium, chloride, and water from the fluid in the kidneys. However, furosemide carries many side effects such as dehydration, low blood pressure, and electrolyte depletion. The medication reduces symptoms such as shortness of breath, and swelling of arms, legs, and abdomen.

Key players operating in the global Furosemide Market are Sanofi, Pfizer Inc., Mylan N.V., Emcure Pharmaceuticals, Sun Pharmaceutical Industries Ltd., SteriMax, and Sandoz Canada Inc.

Request to View Brochure of Report –

Furosemide is indicated for the treatment of edema associated with congestive heart failure, chronic renal failure & other diseases. Rise in prevalence of chronic diseases, increase in number of generic drug manufacturers for furosemide, and growth in number of surgical procedures are expected to drive the furosemide market during the forecast period. Additionally, increase in number of promising drugs in pipeline is anticipated to boost the market during the forecast period

The prevalence of chronic diseases such as heart failure and renal diseases is increasing across the globe. As per the Centre for Disease Control and Prevention (CDC), in the U.S., nearly 5.7 million adults had heart failure in 2016 and half of people with heart failure die within 5 years of diagnosis. According to Emory Healthcare, in the U.S., 550,000 new cases are diagnosed each year. Diabetes and obesity key contributors to rising number of patients with heart failure

Chronic kidney disease is another major health problem. More than 661,000 Americans have kidney failure. According to National Institute of Diabetes and Digestive and Kidney Diseases, more than 661,000 Americans have kidney failure, out of which 468,000 patients are on dialysis, and 193,000 patient live with a functioning kidney transplant. Nearly 47,000 Americans died from kidney disease in 2013.

on September 12 at 12:09

Comments (0)

Become a member and experience a unique opportunity to post blogs, photos, Youtube Vimeo videos, topics, events, and create groups on Robin's Social Networking Site. Use Robin's Social to sell products, services and market your business when posting blogs.

By registering and posting content, you agree to the terms listed at... Posting Terms and Conditions. Enjoy!

© 2020 Content By Members. All Rights Reserved.